740871 VO Arzneimittelsicherheit/Pharmakovigilanz
Sommersemester 2023 | Stand: 22.05.2023 | LV auf Merkliste setzenStudents understand post-marketing surveillance including pharmacovigilance
• Pharmacovigilance obligations post-marketing
• PBRER structure and development
• Post-Authorization studies: safety and efficacy studies,
• Medical Safety assessment, literature search, relevant databases (FAERS, EV, WHO),
• Case Management activities serious vs non-serious ICSR obligations,
• Risk management plan (RMP): concept, development and maintenance
• Risk Benefit Assessment in Pharmacovigilance and its impact on the active subsrance as well as class of compounds,
• Signal Detection activities and methods/Safety Science activitites,
• QPPV role and oversight, PMSF
• Pharmacoepidemiology and its relevance for benefit-risk assessments
Modules 1 and 2
Gruppe 0
|
||||
---|---|---|---|---|
Datum | Uhrzeit | Ort | ||
Mi 24.05.2023
|
13.00 - 14.30 | online (Pharmazie) online (Pharmazie) | ||
Di 30.05.2023
|
09.30 - 11.30 | online (Pharmazie) online (Pharmazie) | ||
Do 01.06.2023
|
09.30 - 11.30 | online (Pharmazie) online (Pharmazie) | ||
Do 29.06.2023
|
09.00 - 11.00 | L.03.121 L.03.121 | Prüfungstermin | |
Mo 10.07.2023
|
10.00 - 12.00 | L.03.121 L.03.121 | Prüfungstermin |